Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Germany
/
Software
/
Exasol
EXL
Exasol
Hybrid Analytics Will Serve Finance And Healthcare Markets
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
11 May 25
Updated
15 Aug 25
6
Set Fair Value
0
votes
Share
AnalystConsensusTarget
's Fair Value
€5.10
36.9% undervalued
intrinsic discount
15 Aug
€3.22
Loading
1Y
46.4%
7D
5.2%
Author's Valuation
€5.1
36.9% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
€5.1
36.9% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-34m
49m
2017
2019
2021
2023
2025
2027
2028
Revenue €49.4m
Earnings €5.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
9.65%
Software revenue growth rate
1.52%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.25%
Calculation
€5.87m
Earnings '28
x
25.15x
PE Ratio '28
=
€147.77m
Market Cap '28
€147.77m
Market Cap '28
/
24.14m
No. shares '28
=
€6.12
Share Price '28
€6.12
Share Price '28
Discounted to 2025 @ 6.28% p.a.
=
€5.10
Fair Value '25